Company Filing History:
3 out of 8 
2 out of 4 
2 out of 832,912 Years Active: 2023-2025
Title: Anthony Rech - Innovator in Drug Delivery Technologies
Introduction
Anthony Rech is a noted inventor based in Jacou, France, recognized for his contributions to the field of drug delivery systems. With a total of four patents to his name, Rech has made significant advancements in methods aimed at treating psychiatric diseases and disorders.
Latest Patents
Among his latest innovations, Rech has developed a patent for drug delivery formulations. This invention focuses on treating psychiatric diseases by administering an injectable formulation that includes risperidone, combined with triblock and diblock copolymers. The formulation is designed to contain a concentration of risperidone ranging from 250-400 mg/mL, with an injection volume not exceeding 1 mL.
Another notable patent is for a biodegradable block copolymer drug delivery composition. This invention consists of a mixture of at least three different block copolymers, of which each can be categorized either as a biodegradable triblock copolymer or a diblock copolymer, paired with a pharmaceutically active ingredient. The careful design of the mixture enables effective drug delivery while minimizing environmental impact.
Career Highlights
Throughout his career, Anthony Rech has worked with reputable organizations such as Medincell, where his expertise in drug delivery technologies has been instrumental in the development of innovative solutions. His work at Medincell has positioned him as a leader in the field.
Collaborations
Rech is known for collaborating with talented individuals, including noteworthy colleagues Christophe Roberge and Jean-Manuel Cros. These collaborations have likely contributed to the success and refinement of his inventions.
Conclusion
In summary, Anthony Rech has established himself as a significant figure in the realm of drug delivery innovations. His patented formulations and compositions reflect a commitment to advancing medical treatments, particularly in psychiatric care. As he continues to push the boundaries of drug delivery technology, his work will undoubtedly leave a lasting impact on the industry.